United Kingdom recommendations for obstetric venous thromboembolism prophylaxis: Evidence and rationale
| Autor: | Andrew Thomson, M. Christy Lamont, Ian A. Greer, Christopher McDermott |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
medicine.medical_specialty Pregnancy Complications Cardiovascular Risk Assessment Body Mass Index 03 medical and health sciences 0302 clinical medicine Pregnancy Risk Factors 030225 pediatrics Humans Medicine cardiovascular diseases Intensive care medicine 030219 obstetrics & reproductive medicine business.industry Postpartum Period Anticoagulants Obstetrics and Gynecology Venous Thromboembolism equipment and supplies medicine.disease Thrombosis United Kingdom Practice Guidelines as Topic Pediatrics Perinatology and Child Health Female Maternal death business Venous thromboembolism |
| Zdroj: | Seminars in Perinatology. 43:222-228 |
| ISSN: | 0146-0005 |
| DOI: | 10.1053/j.semperi.2019.03.008 |
| Popis: | Venous thromboembolism (VTE) is a leading cause of maternal death in the United Kingdom. To address this problem guidance from the Royal College of Obstetricians and Gynaecologists (RCOG) has been developed that recommends the assessment of a woman's risk of thrombosis at specific time-points during pregnancy and postnatally at the time of delivery. The RCOG guidelines provide clinicians with a framework to inform decision-making on the use of thromboprophylaxis and are based on the premise that the higher risk a woman has for VTE, the more likely she is to benefit from prophylaxis - determining her level of risk is based on the number and characteristics of the risk factors that she has. This article will address the pathophysiology of VTE in pregnancy, evidence behind the risk factors for VTE and the use of thromboprophylactic agents. Further, it will reflect on the rationale behind the RCOG guidance. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect